Access to developmental drugs, even when all other available means of treatment have been exhausted, is tightly controlled by the Food and Drug Administration (FDA). The ability of the FDA to deny patients’ access is unacceptable. The Free To Choice Medicine Act provides a new approach to new medicines.
Information
Information describing treatment results from patients using developmental drugs is extremely valuable. Research institutions, medical practitioners, treatment centers, scientists, and patients must be given tools that allow them to observe in real-time, online the effectiveness of promising new drugs. The Free To Choose Medicine Act provides information to those who need it most.
Choice
Choice in medical treatments must be controlled by patients and doctors. The FDA approval system denies individual choice. The Free To Choose Medicine Act enables patients to choose medicines best suited to their needs under the guidance of their care providers.
